Literature DB >> 4392959

1-Isopropylamino-3-(4-indanoxy)-2-propanol HC1: a potent beta-adrenoreceptor antagonist.

B Levy, M Wasserman.   

Abstract

1. The beta-adrenoceptor blocking activity of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCl (USVC 6524) was determined in the anaesthetized dog, the isolated rat uterus and the isolated guinea-pig tracheal strip.2. USVC 6524 inhibited the positive inotropic, positive chronotropic and vasodilator responses to isoprenaline in the dog in a dose of 10 mug/kg and higher. On the basis of comparative pA(2) values, USVC 6524 is approximately 10 times more potent as a beta-adrenoceptor antagonist than propranolol.3. Cardiac depressant effects produced by USVC 6524 were relatively mild and occurred only after the onset of a strong beta-adrenoceptor blockade.4. USVC 6524 also blocked beta-adrenoceptors in the isolated rat uterus and guinea-pig tracheal spiral strip.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4392959      PMCID: PMC1702934          DOI: 10.1111/j.1476-5381.1970.tb09563.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.

Authors:  J W BLACK; A F CROWTHER; R G SHANKS; L H SMITH; A C DORNHORST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

2.  Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide).

Authors:  J W BLACK; J S STEPHENSON
Journal:  Lancet       Date:  1962-08-18       Impact factor: 79.321

3.  Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol.

Authors:  C E POWELL; I H SLATER
Journal:  J Pharmacol Exp Ther       Date:  1958-04       Impact factor: 4.030

4.  Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.

Authors:  H C Stanton; T Kirchgessner; K Parmenter
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

5.  Evaluation of the cardiac effects of several beta adrenergic blocking agents.

Authors:  J R Blinks
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

6.  An analysis of selective beta receptor blockade.

Authors:  B Levy; B E Wilkenfeld
Journal:  Eur J Pharmacol       Date:  1969-02       Impact factor: 4.432

7.  Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.

Authors:  J F Giudicelli; H Schmitt; J R Boissier
Journal:  J Pharmacol Exp Ther       Date:  1969-07       Impact factor: 4.030

8.  The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog.

Authors:  R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1966-02

9.  Effect of beta adrenergic blockade on the cardiovascular dynamics.

Authors:  J Nakano; T Kusakari
Journal:  Am J Physiol       Date:  1966-04

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
  10 in total
  2 in total

1.  Effect of -adrenoceptor blocking agents on poststimulatory atrial flutter in the dog, with observations on the participation of adrenergic mechanisms in this experimental arrhythmia.

Authors:  B R Madan; R K Soni
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

2.  Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.

Authors:  J F Truelove; G R van Petten; R F Willes
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.